H5 influenza vaccines: What needs to be done to reduce the risk of a pandemic As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and ... Science X Medical Xpress

As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.

RSV vaccine 75% effective against hospitalization in older adults, CDC study estimates The respiratory syncytial virus (RSV) vaccine for older adults was 75% effective against hospitalization in its first season of use, adding to the findings of prelicensure trials, according to a test-negative, case-control analysis published today in JAMA. CIDRAP

...

An estimated 60,000 to 160,000 RSV hospital admissions occur each year among US adults aged 65 years and older.

...

FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain

Aug 30 (Reuters) - The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's (NVAX.O)